Vor Biopharma
VOR
VOR
45 hedge funds and large institutions have $43.1M invested in Vor Biopharma in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 18 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40.51% less ownership
Funds ownership: 88.52% → 48.02% (-41%)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
50% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 18
Holders
45
Holding in Top 10
2
Calls
$28K
Puts
$7K
Top Buyers
| 1 | +$193K | |
| 2 | +$140K | |
| 3 | +$123K | |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$100K |
| 5 |
Barclays
London,
United Kingdom
|
+$64K |
Top Sellers
| 1 | -$707K | |
| 2 | -$366K | |
| 3 | -$222K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$95K |
| 5 |
Morgan Stanley
New York
|
-$89.3K |
